COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $892,506 | -57.1% | 238,638 | -51.1% | 0.00% | -100.0% |
Q2 2023 | $2,082,193 | +184.7% | 487,633 | +356.0% | 0.00% | – |
Q1 2023 | $731,477 | +599.1% | 106,941 | +709.5% | 0.00% | – |
Q4 2022 | $104,631 | -54.3% | 13,211 | -44.5% | 0.00% | – |
Q3 2022 | $229,000 | -63.9% | 23,807 | -72.9% | 0.00% | – |
Q2 2022 | $635,000 | -48.6% | 87,809 | -8.2% | 0.00% | – |
Q1 2022 | $1,236,000 | +128.9% | 95,688 | +183.1% | 0.00% | – |
Q4 2021 | $540,000 | -55.3% | 33,806 | -55.0% | 0.00% | – |
Q3 2021 | $1,208,000 | -8.8% | 75,190 | -21.5% | 0.00% | – |
Q2 2021 | $1,325,000 | +115.1% | 95,765 | +126.8% | 0.00% | – |
Q1 2021 | $616,000 | -28.6% | 42,220 | -15.0% | 0.00% | – |
Q4 2020 | $863,000 | +1.5% | 49,680 | +7.2% | 0.00% | -100.0% |
Q3 2020 | $850,000 | +286.4% | 46,338 | +276.7% | 0.00% | – |
Q2 2020 | $220,000 | -3.5% | 12,300 | -2.9% | 0.00% | – |
Q4 2019 | $228,000 | +2.7% | 12,671 | +15.7% | 0.00% | – |
Q3 2019 | $222,000 | -47.6% | 10,950 | -42.9% | 0.00% | -100.0% |
Q2 2019 | $424,000 | +53.1% | 19,189 | -0.5% | 0.00% | 0.0% |
Q2 2017 | $277,000 | – | 19,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |